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ABSTRACT
Objective: To study two different mod-
els of obesity, exocrine and endocrine, 
and its association on tail arterial pres-
sure (TAP), body weight (BW), glucose 
metabolism and visceral fat content. 
Methods: Male Wistar rats were stud-
ied. The MSG group was composed by 
rats that received of MSG in neonatal 
period. At the 3rd month of life, part 
of these animals received cafeteria diet. 
Animals received saline control in the 
neonatal period. In the 12 weeks of 
study, body weight and blood pressure 
were measured twice a week. In the end 
of this period on, Oral Glucose Toler-
ance Test (OGTT) was performed and 
the Insulin Sensitivity Index (ISI) was 
calculated, also the left Relative Ven-
tricular Weight (RLW) and Relative 
Epididimal Fat Weight (REFW) were 
obtained. Results: No changes on BW 
and TAP were verified. The obesity 
induced by MSG and CAF, individu-
ally, let to increases on insulin resist-
ance (WST = 23,25 ± 9,31; CAF = 
15,92 ± 9,10*; MSG = 13,41 ± 3,84* 
mg-1mU-1, p < 0,05 vs WST) and 
relative epididimal fat content (WST 
= 6,20 ± 0,57; CAF = 8,27 ± 1,53*; 
MSG = 8,23 ± 1,98* g/100 g, *p < 
0,05) when these rats were compared 
to control rats. An enhanced effect 
upon these parameters was observed 
with the association of both obesity 
models (MSG+CAF = 9,34 ± 5,77 mg-
1mU-1, p < 0,05 vs MSG and CAF) and 
visceral fat content (MSG+CAF = 11,12 
± 3,85 g/100g, p < 0,05 vs MSG and 
CAF). Conclusion: The association of 
these two experimental models of obes-
ity aggravates insulin resistance that 
probably is due at least in part to the 
increase of visceral fat content.
Keywords: obesity; blood pressure; in-
sulin resistance; metabolic syndrome X; 
rats, Wistar.
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INTRODUCTION
Obesity is one of the major problems of 
public health in developed and developing 
countries, regardless of the economic and 
social conditions. Evidence has suggested 
that the prevalence of overweight and obe-
sity has increased at an alarming rate.1
In human beings and experimental 
animals, obesity results from the unbalan-
ce between energy intake and expenditure 
for maintaining vital processes. Thus, obe-
sity can be triggered when there is excessi-
ve calorie intake without a corresponding 
increase in energy expenditure, or when, 
even in the presence of normal calorie in-
take, metabolic disorders occur in the use 
of substrates.2
The high incidence of obesity and its 
association with risk factors, such as dia-
betes mellitus, dyslipidemia, and arterial 
hypertension, increase mortality due to 
cardiovascular diseases.3
The coexistence of arterial hyper-
tension and obesity increases the risk of 
cardiovascular disease, and is frequently 
associated with dyslipidemia and glucose 
intolerance, making the possibilities of 
angina pectoris, myocardial infarction, 
heart failure, stroke, and sudden death 
even more frequent.4
Human obesity is known to be a 
multifactorial disease, thus, controlling 
each variable involved in its etiology is 
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impossible. Experimental models allow the control-
led study of each variable involved in the physiopa-
thology of obesity.
The experimental models of obesity comprise 
the induced models that imitate the western diet 
with high calorie intake (called cafeteria diet) and 
those with neonatal administration of monoso-
dium glutamate (MSG), a neuroexcitatory amino 
acid that destroys neurons of the arcuate nucleus 
of the hypothalamus.5 Other experimental models, 
in which obesity can be studied in obese rats and 
mice, are the genetic models based on the reduced 
leptin action.
In those induced models, an increase in body 
weight and in insulin resistance has been observed. 
However, studies assessing blood pressure alteration 
in those experimental models are still controversial. 
Insulin resistance and hyperinsulinemia are factors 
that can cause an increase in blood pressure.6
To assess the effect of those two models of obe-
sity on blood pressure, we studied rats receiving 
monosodium glutamate in the neonatal period and 
cafeteria diet for 12 weeks and assessed tail blood 
pressure, body weight, glucose metabolism, and vis-
ceral fat content. This study also aimed at assessing 
the effect of the association of those two models of 
obesity on the parameters studied.
 
METHODS
This study used male Wistar rats, kept in cages (ma-
ximum of five animals per cage) at the Universidade 
Federal de São Paulo. The protocol of this study was 
reviewed and approved by the Committee on Ethics 
of the Universidade Federal de São Paulo – Escola 
Paulista de Medicina (protocol nº 0310/07).
On the day following birth, the animals were 
separated and part of them began to receive sub-
cutaneous injections of 2 mg/kg/day of MSG up to 
the 11th day of life. The other animals received the 
same volume of saline solution. Upon completion 
of three months of life, part of the animals recei-
ving the neonatal MSG injections had their stan-
dard food preparation replaced by cafeteria diet 
(MSG+CAF, n = 10). The other MSG animals conti-
nued to receive the standard diet (MSG, n = 9). Part 
of the animals receiving saline solution in the neo-
natal period also received cafeteria diet (CAF, n = 
14), while others continued to receive the standard 
diet (WST, n = 8). The cafeteria diet is composed of 
standard food preparation (37.5%), corn crackers 
(12.5%), toasted peanuts (25%), and granular 
chocolate (25%). All groups were followed up for 
12 consecutive weeks.
All groups had their tail blood pressure, by use 
of the oscillometric method, and body weight mea-
sured twice a week. Prior to inclusion in the study, 
two baseline measurements of tail blood pressure 
and body weight were taken. The animals with ba-
seline tail blood pressures greater than 140 mm Hg 
were excluded from the study. The mean values of 
two tail blood pressure and body weight measure-
ments per week were used as representative of that 
week.
After a 12-week follow-up of tail blood pres-
sure and body weight measurements, the animals 
underwent an oral glucose tolerance test, for which 
they were anesthetized and a polyethylene catheter 
was inserted in the left femoral artery. That cathe-
ter traveled along the subcutaneous tissue and was 
fixed on the animal’s dorsum. 
After a 12-hour fasting, approximately 1.0 
milliliter of blood was collected from each animal 
through the arterial catheter for measuring fasting 
glycemia and serum insulin level. After that, the rats 
received 68 mg/kg of anhydrous glucose solution 
through gavage. New blood samples were collected 
at 15, 30, 60, 90, and 120 minutes after glucose 
administration for determining serum insulin level 
and glycemia.
Plasma glucose was measured by use of a gluco-
se meter (Accu-Chek – Advantage) and appropriate 
test strips (Accu-Chek Advantage II). For measu-
ring serum insulin level, the blood samples collec-
ted in Eppendorf tubes were centrifuged (Eppendorf 
Centrifuge S403) at 3,000 rpm for 10 minutes and 
stored at -70º C in the freezer (Revco Scientific Inc. 
Asheville, NC, USA). 
After the glucose and insulin measurements we-
re taken, the areas under the curves for glucose and 
insulin were calculated (AUCG and AUCI, respecti-
vely) by determining the weighted average of glyce-
mia and serum insulin level throughout the entire 
oral glucose tolerance test. Then, the insulin sen-
sitivity index (ISI) was calculated by dividing the 
factor 10,000 by the product of the areas under the 
curves for glucose and insulin. The result is expres-
sed as mg1.mU1.
After the oral glucose tolerance test, the animals 
were once again anesthetized and the right and left 
ventricles, as well as the epididymal fat, were dissected 
and weighed in an analytical scale (Gehara, BG440). 
The relative weight of the organs was calculated by 
dividing the organ mass by the body weight.
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Statistical analysis was performed by use of 
repeated-measures analysis of variance (One Way 
RM ANOVA) for comparing the temporal varia-
tions of tail blood pressure and body weight wi-
th baseline values. Analysis of variance was used 
(One Way ANOVA) for comparing the means of 
four sets of observations for which a parametric 
test is applicable: absolute weights of heart, left 
ventricle, and epididymal fat, glycemia, serum 
insulin level. Non-parametric analysis of varian-
ce (ANOVA ON RANKS) was used to compare 
the means of two sets of observations for which a 
non-parametric test is applicable: AUCG, AUCI, 
ISI, relative weights of the heart, left ventricle, and 
epididymal fat, and delta variation of body weight 
and tail blood pressure. In all tests, the significan-
ce level of 5% was adopted (p < 0.05).
 
RESULTS
BODY WEIGHT (TABLE 1)
The analysis of body weight in all experimental groups 
showed a significant increase at the 12th week as 
compared with body weight at baseline. When com-
paring the values of body weight at the 12th week, the 
MSG group showed the greatest gain in body weight, 
which was significantly greater than the one obtained 
in MSG+CAF rats. The weight gain of WST and CAF 
rats was similar.
TAIL BLOOD PRESSURE (TABLE 1)
The comparison between initial and final tail blood 
pressure in the Wistar Control (WST), Wistar MSG 
(MSG), Wistar Cafeteria (CAF), and Wistar MSG 
Cafeteria (MSG+CAF) groups showed no statistical 
differences.
Table 1 
ABSOLUTE VALUES OF BODY WEIGHT (BW, grams), TAIL BLOOD PRESSURE (TBP, mmHg), INSULIN SENSITIVITY   
  INDEX (ISI, mg-1mU-1), AREAS UNDER THE CURVES FOR GLUCOSE (AUCG, mg/dL) AND INSULIN (AUCI, mU/L),  
   AND RELATIVE EPIDIDYMAL FAT (REF, g/100g) IN THE GROUPS STUDIED
   WST CAF MSG MSG+CAF
BW (baseline) 226 ± 10.13 285.63 ± 16.73 220.79 ± 6.40 273.75 ± 29.6
BW (12 weeks) 294.38 ± 15.86 343.14 ± 29.53   363.75 ± 18.98 403.50 ± 46.55*
TBP (baseline) 119.38 ± 7.76 120.79 ± 3.02 121.75 ± 5.78 120.00 ± 11.28
TBP (12 weeks) 122.25 ± 7.03 123.93 ± 2.89 118.00 ± 5.81 120.17 ± 5.08
ISI   23.25 ± 9.31 15.92 ± 9.10* 13.41 ± 3.84* 9.34 ± 5.77*#@
AUGC   120.87 ± 19.68 191.45 ± 71.03* 143.59 ± 32.97* 231.60 ± 61.97*#@
AUCI  3.96 ± 0.96 5.22 ± 3.73* 5.58 ± 1.07* 5.96 ± 2.87*
REF   6.20 ± 0.57 8.27 ± 1.53* 8.23 ± 1.98* 11.12 ± 3.85*@
Values shown as mean ± standard deviation. *p < 0.05 vs. WST, #p < 0.05 vs. CAF and @p < 0.05 vs. MSG.
Figure 1. Values of mean ± standard error of the insulin 
sensitivity index (mg-1 mU-1) of the groups studied. *p < 
0.05 vs. WST; @p < 0.05 vs. MSG and #p < 0.05 vs. CAF.
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AREA UNDER THE CURVE FOR GLUCOSE (AUCG) AND 
AREA UNDER THE CURVE FOR INSULIN (AUCI) (TABLE1)
The induction of obesity produced a significant in-
crease in the areas under the curve for glucose and 
insulin in the CAF, MSG and MSG+CAF groups as 
compared with those of WST rats. In MSG+CAF 
animals, a significant increase in the AUCG was 
observed when those animals were compared with 
CAF and MSG rats separately. No difference was 
observed in the AUCI between the groups of ani-
mals treated.
INSULIN SENSITIVITY INDEX (ISI) (TABLE 1, FIGURE 1)
The administration of the cafeteria diet caused a signifi-
cant decrease in ISI in the MSG, CAF, and MSG+CAF 
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groups. The association between neuroendocrine 
and exocrine obesity produced a synergic reduc-
tion in the ISI of the MSG + CAF group (MSG + 
CAF = 9.34 ± 5.77 mg-1mU-1 & p < 0.05 vs. CAF, 
*p < 0.05 vs. MSG).
ABSOLUTE WEIGHT OF EPIDIDYMAL FAT (TABLE 1, FIGURE 2)
All obese groups showed a significant increase in 
epididymal fat when compared with the control 
WST group. Even when corrected by body wei-
ght, the epididymal fat continued increased in 
MSG+CAF rats.
LEFT VENTRICULAR WEIGHT
The analysis of the absolute left ventricular weight 
showed no variation in the groups (WST = 0.63 
± 0.06; MSG = 0.63 ± 0.07; CAF = 0.70 ± 0.07; 
MSG + CAF = 0.54 ± 0.07). A reduction in the 
absolute ventricular weight of MSG+CAF rats is 
observed, due to the greater body weight in that 
group.
DISCUSSION
This study assessed the effect of producing obesity 
and insulin resistance by use of two experimen-
tal models of neuroendocrine and exocrine obesi-
ty, and the effect of the association of the models 
on glucose metabolism and tail blood pressure of 
normotensive Wistar rats. Separately, both expe-
rimental models caused an increase in insulin re-
sistance, and, when associated, they produced a 
synergic effect on insulin resistance. The increase 
in insulin resistance in those animals may be cor-
related with an increase in the amount of visceral 
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Figure 2. Values of mean ± standard error of the 
relative epididymal fat (grams/100grams of the rat) of 
the groups studied, @p < 0,05 vs. MSG.
fat. None of the experimental groups showed any 
alteration in tail blood pressure.
When analyzing the body weight of the animals, 
some important aspects should be stressed. In the 
first 12 weeks of the follow-up period, the grea-
test body weight gain was observed in MSG rats 
(+65%), followed by the rats receiving MSG+CAF 
(+47%). The administration of the cafeteria diet 
did not cause additional body weight gain as com-
pared with that of the standard diet group. Data 
referring to body weight alterations in rats induced 
to obesity by the neonatal MSG administration are 
controversial7,8 and previous studies by this rese-
arch group have evidenced no weight gain alte-
ration in those animals. However, MSG animals 
are known to have a reduced secretion of growth 
hormone9 and an increased secretion of cortisol,10 
and, thus, the weight gain in MSG and MSG+CAF 
animals is mainly due to the increase in visceral 
fat. Although the animals receiving the hypercalo-
ric diet did not have an increase in body weight, 
they also had an increase in visceral fat.11 This is 
mainly due to the fact that animals receiving a 
hypercaloric diet reduce their daily food intake, 
but, because of the high amount of carbohydrates 
and fat contained in the cafeteria diet, visceral fat 
builds up.12
The increase in cardiovascular risk is more as-
sociated with the distribution of visceral fat than 
with the mere increase in body weight.3 Studies 
on the oriental population have already evidenced 
that patients with increased visceral fat, despite 
their normal body weight, had an increased pre-
valence of cardiovascular diseases.3 In this study, 
all experimental animals had an increase in epidi-
dymal fat and the greatest increase in that para-
meter occurred in the group associating the two 
models of obesity: exocrine and neuroendocrine 
(MSG+CAF group).
The increase in visceral fat results in a series of 
metabolic alterations, such as the production of 
adipokines13,14 and/or decrease in the metabolism 
of cortisol,15 which can culminate in an increase 
in blood pressure and in peripheral resistance to 
insulin action.16 Hyperleptinemia secondary to the 
increase in visceral fat could activate the sympa-
thetic nervous system, with higher secretion of 
catecholamines, leading to an increase in blood 
pressure and insulin resistance.17 Nevertheless, our 
animals had no alterations in blood pressure. It is 
worth emphasizing, however, that Wistar animals 
receiving MSG during the neonatal period increase 
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their adrenergic activity, since a previous study of 
ours has already shown that those animals have an 
increase in heart rate and in total peripheral resis-
tance.10 Studies reporting an increase in thermo-
genesis of rats receiving the cafeteria diet support 
the fact that those animals also have an increase 
in sympathetic activity.1 The lack of alteration in 
blood pressure in our rats could be attributed to 
the short duration of the study.
However, the increase in the sympathetic acti-
vity associated with an increase in visceral fat has 
determined metabolic alterations that culminate 
in increased insulin resistance.18 When the large 
amount of free fatty acids, originating from vis-
ceral fat, arrive at the liver, it causes an increase 
in gluconeogenesis, a decrease in muscle glucose 
uptake, and a reduction in the liver metabolism 
of insulin. It is worth emphasizing that the expe-
rimental models, when studied separately, showed 
an increase in epididymal fat and insulin resistan-
ce. When both stimuli were associated, a greater 
deposition of visceral fat and a synergic effect 
on insulin resistance were observed. The experi-
mental model used contributes to the study of the 
metabolic repercussions that occur when human 
beings, who already have a genetic/neuroendocri-
ne component, undergo an exocrine stimulus, or 
the administration of a hypercaloric diet, a con-
dition that has become increasingly common with 
modern life.
It is worth stressing that the decrease in the 
ventricular mass observed in MSG+CAF rats can 
be attributed to the body weight of those animals 
at the end of the study. Maybe the use of a mo-
re reliable parameter for that situation, such as 
correction by the shin bone, would be required to 
confirm that value.10
 
CONCLUSIONS
In conclusion, this study shows that the administra-
tion of a cafeteria diet potentiates the effect of the ne-
onatal administration of monosodium glutamate on 
insulin resistance and that increase could be attribu-
ted to the great increase in visceral obesity observed 
in the animals.
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